External /dna-to-rna/taxonomy/term/4/all en D2R announces new round of funding, investing $1.5 million to advance research in RNA therapeutics and to support Â鶹AV Centres and Institutes /dna-to-rna/channels/news/d2r-announces-new-round-funding-investing-15-million-advance-research-rna-therapeutics-and-support-362236 <p><strong>Montreal – December 19, 2024</strong> – The D2R (DNA to RNA) Initiative is proud to announce the recipients of its latest round of funding, awarding a total of $1.5 million to four principal investigators and five Â鶹AV Centres and Institutes. These awards are designed at advancing research in RNA therapeutics by facilitating industry collaboration and supporting the next generation of scientific leaders as well as research Centres and Institutes.</p> Thu, 19 Dec 2024 14:21:57 +0000 emily.cholette2@mcgill.ca 1104 at /dna-to-rna CQDM partners with D2R to enhance collaborations among researchers and industry in RNA research /dna-to-rna/channels/news/cqdm-partners-d2r-enhance-collaborations-among-researchers-and-industry-rna-research-361502 <p><b>Montréal, November 28th</b> – CQDM is proud to announce a strategic partnership with the D2R (DNA to RNA) Initiative at Â鶹AV, aimed at funding translational research projects carried out through collaborations between researchers and industry. This alliance seeks to support and accelerate the development and commercialization of innovative RNA-based therapies. It aims to provide patients with safer and more effective therapeutic options, particularly for treating cancer, rare diseases, and preventing various infectious diseases.</p> Thu, 28 Nov 2024 14:00:00 +0000 emily.cholette2@mcgill.ca 1086 at /dna-to-rna Research | A new trial hopes to use mRNA to halt the devastating progression of Creutzfeldt-Jakob Disease /dna-to-rna/channels/news/research-new-trial-hopes-use-mrna-halt-devastating-progression-creutzfeldt-jakob-disease-361983 <p>Prion diseases came to public attention during the 1980s and ’90s, when Mad Cow Disease was in the news. While transmission to humans from infected beef has largely been eliminated, other forms of these devastating diseases are unfortunately still around, like Creutzfeld-Jacob Disease (CJD). In fact, according to the US Centers for Disease Control, cases of CJD have been on the rise in the last two decades.</p> Mon, 09 Dec 2024 19:50:19 +0000 emily.cholette2@mcgill.ca 1096 at /dna-to-rna Event | Seminar, The power of first impressions: Using viral imprinting for broadly reactive vaccine development | Dec 11, 2024 /dna-to-rna/channels/news/event-seminar-power-first-impressions-using-viral-imprinting-broadly-reactive-vaccine-development-361584 <p>The Emerging Topics in Health (EToH) seminar series is cohosted by the Departments of Microbiology and Immunology, Physiology and Human Genetics, the Goodman Cancer Institute (GCI), the Â鶹AV Research Centre on Complex Traits (MRCCT), and M[i]4. The organizers invite guest speakers to talk about their current research. This seminar series is part of the Current Topics & Seminars course and is open for attendance by MIMM students and all interested individuals.</p> <p><strong>Details about upcoming seminar: </strong></p> Fri, 29 Nov 2024 16:59:29 +0000 emily.cholette2@mcgill.ca 1092 at /dna-to-rna Event | MI4 6th Annual Scientific Symposium | December 4, 2024 /dna-to-rna/channels/news/event-mi4-6th-annual-scientific-symposium-december-4-2024-361255 <p>Join MI4 for the <b>6th Annual Scientific Symposium</b> on Wednesday, December 4, 2024, from 11:30 PM to 5:30 PM at the Â鶹AV Faculty Club. This year’s theme, <i>"Microbiome: Decoding the Invisible World,"</i> promises an engaging lineup, including a keynote by Prof. Yasmine Belkaid, President of Institut Pasteur. Don’t miss this chance to hear groundbreaking insights from leading experts in the MI4 community.</p> Fri, 15 Nov 2024 21:17:47 +0000 emily.cholette2@mcgill.ca 1083 at /dna-to-rna Event | Practical examples of research in indigenous context | November 20, 2024 /dna-to-rna/channels/news/event-practical-examples-research-indigenous-context-november-20-2024-361252 <p>D2R partner, <strong>Tahatikonhsontóntie' Quebec Network Environment for Indigenous Health Research,</strong> is organizing a webinar "Practical examples of research in Indigenous context" on November 20 from 12-1:30pm. </p> <p>Guest speakers include: </p> Fri, 15 Nov 2024 21:04:13 +0000 emily.cholette2@mcgill.ca 1081 at /dna-to-rna Event | Antisense oligonucleotide therapy in an individual with KIF1A-associated neurological disorder | November 14, 2024 /dna-to-rna/channels/news/event-antisense-oligonucleotide-therapy-individual-kif1a-associated-neurological-disorder-november-361123 <p>Dear Colleagues,</p> <p>Please see the next Medical Genetics Grand Rounds scheduled talk below:</p> Tue, 12 Nov 2024 14:30:50 +0000 emily.cholette2@mcgill.ca 1078 at /dna-to-rna D2R welcomes RNA and genomic researchers to Université de Sherbrooke /dna-to-rna/channels/news/d2r-welcomes-rna-and-genomic-researchers-universite-de-sherbrooke-360795 <h3><b>D2R welcomes RNA and genomic researchers to Université de Sherbrooke</b></h3> <p>Montreal – October 31, 2024 – Â鶹AV’s DNA to RNA (D2R) research initiative is proud to announce the appointment of three new researchers at Université de Sherbrooke, marking the inaugural recipients of the D2R’s New Faculty Start-Up funding program. Université de Sherbrooke is a partner institution in the D2R initiative, working collaboratively to advance genomic and RNA research.</p> Thu, 31 Oct 2024 12:09:26 +0000 emily.cholette2@mcgill.ca 1053 at /dna-to-rna Philippe Gros appointed Chief Scientific Officer of D2R /dna-to-rna/channels/news/philippe-gros-appointed-chief-scientific-officer-d2r-360796 <h3>Philippe Gros appointed Chief Scientific Officer of D2R</h3> <p>Philippe Gros has been appointed Chief Scientific Officer (CSO) of Â鶹AV’s DNA to RNA (D2R) Initiative, effective September 30, 2024. Prior to this role, he served as Deputy Vice-President (Research and Innovation) at Â鶹AV. This appointment follows a thorough international search, with the selection committee enthusiastic about their recommendation. Notably, Gros was instrumental in writing the application for the D2R Initiative, laying the groundwork for its success.</p> Thu, 31 Oct 2024 12:20:10 +0000 emily.cholette2@mcgill.ca 1055 at /dna-to-rna D2R Breakfast & Learn with Pac Bio /dna-to-rna/channels/event/d2r-breakfast-learn-pac-bio-359576 <p>Are you preparing an application for <b>D2R | DNA to RNA</b> funding programs?</p> Thu, 12 Sep 2024 18:55:01 +0000 emily.cholette2@mcgill.ca 976 at /dna-to-rna Seminar: The Wellcome Leap R3 Program: RNA Readiness and Response /dna-to-rna/channels/event/seminar-wellcome-leap-r3-program-rna-readiness-and-response-360576 <p style="text-align:center"><strong>Join D2R and the Victor Phillip Dahdaleh Institute of Genomic Medicine for this hybrid seminar on Tuesday November 26 at 9am (EST) titled "The Wellcome Leap R3 Program: RNA Readiness and Response".</strong></p> Mon, 21 Oct 2024 12:42:04 +0000 emily.cholette2@mcgill.ca 1042 at /dna-to-rna News | 2024 Nobel Prize awarded to Victor Ambros and Gary Ruvkun for the discovery of microRNA and its role in post-transcriptional gene regulation /dna-to-rna/channels/news/news-2024-nobel-prize-awarded-victor-ambros-and-gary-ruvkun-discovery-microrna-and-its-role-post-360261 <h4>The 2024 Nobel Prize in Physiology or Medicine has been awarded to Victor Ambros and Gary Ruvkun for the discovery of microRNA and its role in post-transcriptional gene regulation.</h4> Tue, 08 Oct 2024 19:41:27 +0000 emily.cholette2@mcgill.ca 1018 at /dna-to-rna Event | Practical research experience in a First Nations environment in the field of health and social services evaluation | Dec 20, 2024 /dna-to-rna/channels/news/event-practical-research-experience-first-nations-environment-field-health-and-social-services-360447 <h3>Practical research experience in First Nations communities in the field of health and social services evaluation</h3> <p><br /> <strong>December 20, 2024 | 12 h à 13 h<br /> Speaker: Cecilia Valdebenito, anthropologist</strong></p> <p>This webinar has two objectives:</p> Tue, 15 Oct 2024 18:42:45 +0000 emily.cholette2@mcgill.ca 1038 at /dna-to-rna Event | Controlling RNA Sequence for Diagnostics and Therapeutic Delivery | January 5-10, 2025 /dna-to-rna/channels/news/event-controlling-rna-sequence-diagnostics-and-therapeutic-delivery-january-5-10-2025-360257 <h3>RNA Nanotechnology - Gordon Research Conference (GRC)</h3> Controlling RNA Sequence for Diagnostics and Therapeutic Delivery <p><strong>January 5 - 10, 2025</strong></p> <p><strong>Ventura, California, United States</strong></p> Tue, 08 Oct 2024 18:31:06 +0000 emily.cholette2@mcgill.ca 1017 at /dna-to-rna Congratulations to Dr. Raquel Cuella Martin on receiving Gairdner Foundation Early Career Investigator Award /dna-to-rna/channels/news/congratulations-dr-raquel-cuella-martin-receiving-gairdner-foundation-early-career-investigator-360187 <p>Congratulations to Dr. Raquel Cuella Martin on receiving the prestigious Gairdner Foundation Early Career Investigator Award.<br /> <br /> As an Assistant Professor of Human Genetics at Â鶹AV, Dr. Cuella Martin is pushing the boundaries of science with her lab, which uses precision genome editing to tackle complex biological problems.<br /> <br /></p> Thu, 03 Oct 2024 14:52:53 +0000 emily.cholette2@mcgill.ca 1001 at /dna-to-rna